Praxis Precision Medicines Inc (NAS:PRAX)
$ 295.81 -19.96 (-6.32%) Market Cap: 8.25 Bil Enterprise Value: 7.46 Bil PE Ratio: 0 PB Ratio: 5.85 GF Score: 38/100

Praxis Precision Medicines Inc at Goldman Sachs Healthcare Conference Transcript

Jun 8, 2026 / 12:00 PM GMT
Release Date Price: $253.25 (-0.30%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRAX.OQ - Praxis Precision Medicines Inc
Praxis Precision Medicines Inc at Goldman Sachs Healthcare Conference
Jun 08, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Great. So welcome, everyone. It's my pleasure to introduce the President and CEO, Marcio Souza, and the CFO, Tim Kelly, of Praxis Precision Medicine.

My name is Kevin Strang. I'm one of the biotech analysts at Goldman Sachs.

And yeah, so welcome.

To start us off, maybe for those that are kind of newer to the story.

Would you mind giving a brief introduction and maybe, what you view as your core competencies and philosophy as a company?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, absolutely. I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot